Sex differences in cardiovascular outcomes, pharmacological treatments and indicators of care in patients with newly diagnosed diabetes: Analyses on administrative database

European Journal of Internal Medicine

Volumn 25, Issue 3, 2014, Pages 270-275

  Baviera, Marta ^a   Santalucia, Paola ^b   Cortesi, Laura ^a   Marzona, Irene ^a   Tettamanti, Mauro ^a   Avanzini, Fausto ^a   Nobili, Alessandro ^a   Riva, Emma ^a   Caso, Valeria ^c   Fortino, Ida ^d   Bortolotti, Angela ^d   Merlino, Luca ^d   Roncaglioni, Maria Carla ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d Regional Health Ministry   (Italy)

Author keywords

Cardiovascular outcome; Mortality; Newly diagnosed diabetes; Sex differences

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BIGUANIDE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; INSULIN; SULFONYLUREA; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRESCRIPTION; PROPORTIONAL HAZARDS MODEL; REVASCULARIZATION; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT OUTCOME; VERY ELDERLY; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FACTUAL DATABASE; HEALTH CARE QUALITY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; QUALITY INDICATORS, HEALTH CARE; SEX FACTORS; TREATMENT OUTCOME;

EID: 84896401806     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2014.01.022     Document Type: Article

References (46)

1. International Diabetes Federation Diabetes Atlas. Epidemiology and morbidity http://www.diabetesatlas.org/content/epidemiology-and-morbidity 2011
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
3. L. Monesi, M. Baviera, I. Marzona, F. Avanzini, G. Monesi, and A. Nobili et al. Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based Diabet Med 28 2011 1 8
4. R. Huxley, F. Barzi, and M. Woodward Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies BMJ 332 2006 73 78
5. A. Juutilainen, S. Kortelainen, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 2004 2898 2904
6. T. Almdal, H. Scharling, J.S. Jensen, and H. Vestergaard The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke and death Arch Intern Med 164 2004 1422 1426
7. A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, and F. Lombardo et al. Incidence of coronary heart disease in type 2 diabetes men and women. Impact of microvascular complications, treatment, and geographic location Diabetes Care 30 2007 1241 1247
8. F.B. Hu, M.J. Stampfer, C.G. Solomon, S. Liu, W.C. Willett, and F.E. Speizer et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women. 20 years of follow-up Arch Intern Med 161 2001 1717 1723
9. G. Hu, P. Jousilahti, Q. Qiao, S. Katoh, and J. Tuomilehto Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction Diabetologia 48 2005 856 861
10. E.W. Gregg, Y.J. Cheng, S. Saydah, C. Cowie, S. Garfield, and L. Geiss et al. Trends in death rates among U.S. Adults with and without diabetes between 1997 and 2006. Findings from the National Health Interview Survey Diabetes Care 35 2012 1252 1257
11. S.R. Preis, S.J. Hwang, S. Coady, M.J. Pencina, R.B. D'Agostino, and P.J. Savage et al. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005 Circulation 119 2009 1728 1735
12. J. Charlton, R. Latinovic, and M.C. Gulliford Explaining the decline in early mortality in men and women with type 2 diabetes. A population-based cohort study Diabetes Care 31 2008 1761 1766
13. A.M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the sex difference in coronary heart disease mortality among patients with diabetes mellitus Arch Intern Med 162 2002 1737 1745
14. A. Norhammar, U. Stenestrand, J. Lindbäck, L. Wallentin On behalf of the Register for Information and Knowledge about Swedish heart Intensive Care Admission (RIKS-HIA) Women younger than 65 years with diabetes mellitus are a high-risk group after myocardial infarction: a report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA) Heart 94 2008 1565 1570
15. A. Norhammar, and K. Schenck-Gustafsson Type 2 diabetes and cardiovascular disease in women Diabetologia 56 2013 1 9
16. C.D. Furberg, B.M. Psaty, T.A. Manolio, J.M. Gardin, V.E. Smith, and P.M. Rautaharju Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study) Am J Cardiol 74 1994 236 241
17. W.L. Lee, A.M. Cheung, D. Cape, and B. Zinman Impact of diabetes on coronary artery disease in women and men. A meta-analysis of prospective studies Diabetes Care 23 2000 962 968
18. A.P. Dantas, Z.B. Fortes, and M.H. de Carvalho Vascular disease in diabetic women: why do they miss the female protection? Exp Diabetes Res 2012 10.1155/2012/570598
19. B.V. Howard, L.D. Cowan, O. Go, T.K. Welty, D.C. Robbins, and E.T. Lee Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study Diabetes Care 21 1998 1258 1265
20. C.E. Walden, R.H. Knopp, P.W. Wahl, K.W. Beach, and E. Strandness Jr. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations N Engl J Med 311 1984 953 959
21. H.O. Steinberg, G. Paradisi, J. Cronin, K. Crowde, A. Hempfling, and G. Hook et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women Circulation 101 2000 2040 2046
22. R.R. Kalyani, M. Lazo, P. Ouyang, E. Turkbey, K. Chevalier, and F. Brancati et al. Gender differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults Diabetes Care 2013
23. G. Hu, and for the DECODE Study Group Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes Diabetologia 46 2003 608 617
24. S. Natarajan, Y. Liao, G. Cao, S.R. Lipsitz, and D.L. McGee Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease Arch Intern Med 163 2003 1735 1740
25. A.H. Maas, Y.T. van der Shouw, V. Regitz-Zgrosek, E. Swahn, Y.E. Appelman, and G. Pasterkamp et al. Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010 Eur Heart J 32 2001 1362 1368
26. A.L. Blomkalns, A.Y. Chen, J.S. Hochman, E.D. Peterson, K. Trynosky, and D.B. Diercks et al. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative J Am Coll Cardiol 45 2005 832 837
27. C.N. Bairey Merz, L.J. Shaw, S.E. Reis, V. Bittner, S.F. Kelsey, and M. Olson et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease J Am Coll Cardiol 47 2006 S21 S29
28. A. Elsaesser, and C.W. Hamm Acute coronary syndrome: the risk of being female Circulation 109 2004 565 567
29. J.M. Ahmed, G. Dangas, A.J. Lansky, R. Mehran, M.K. Hong, and G.S. Mintz et al. Influence of gender on early and one-year clinical outcomes after saphenous vein graft stenting Am J Cardiol 87 2001 401 405
30. C.A. Thompson, A.V. Kaplan, B.J. Friedman, J.E. Jayne, B.R. Gerling, and N.W. Niles et al. Gender-based differences of percutaneous coronary intervention in the drug-eluting stent era Catheter Cardiovasc Interv 67 2006 25 31
31. Y. Liu, L.F. Wang, X.F. Yang, Y.G. Ge, H.G. Wang, and L. Xu et al. Gender differences in efficacy of primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction Chin Med J 121 2008 2374 2378
32. M. Gulati, R.M. Cooper-DeHoff, C. McClure, B.D. Johnson, L.J. Shaw, and E.M. Handberg et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project Arch Intern Med 169 2009 843 850
33. C. Usher, K. Bennett, and J. Feely Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland Pharmacoepidemiol Drug Saf 14 2005 537 544
34. D.J. Wexler, R.W. Grant, J.B. Meigs, D.M. Nathan, and E. Cagliero Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes Diabetes Care 28 2005 514 520
35. H.U. Krämer, E. Raum, G. Rüter, B. Schöttker, D. Rothenbacher, and T. Rosemann et al. Gender disparities in diabetes and coronary heart disease medications among patients with type 2 diabetes: results from the DIANA study Cardiovasc Diabetol 11 2012 88
36. P.M. Ridker, N.R. Cook, I.M. Lee, D. Gordon, J.M. Gaziano, and J.E. Manson et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in females N Engl J Med 352 2005 1293 1304
37. J.S. Berger, M.C. Roncaglioni, F. Avanzini, I. Pangrazzi, G. Tognoni, and D.L. Brown Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 2006 306 313
38. V. Caso, P. Santalucia, M. Acciaresi, F.R. Pezzella, and M. Paciaroni Antiplatelet treatment in primary and secondary stroke prevention in women Eur J Intern Med 23 2012 580 585
39. L. Mosca, H. Mochari-Greenberger, R.J. Dolor, L.K. Newby, and K.J. Robb Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health Circ Cardiovasc Qual Outcomes 3 2010 120 127
40. A. Gupta, J.F. Lamporopulos, B. Bikdeli, P. Mody, R. Chen, and V.T. Kulkarni et al. Most important outcomes research papers on cardiovascular disease in women Circ Cardiovasc Qual Outcomes 6 2013 e1 e7
41. N.A. Papakonstantinou, M.I. Stamou, N.G. Baikoussis, J. Goudevenos, and E. Apostolakis Sex differentiation with regard to coronary artery disease J Cardiol 62 2013 4 11
42. N. Yurgin, K. Secnik, and M.J. Lage Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study Clin Ther 29 2007 316 325
43. D. de Zeeuw, H.H. Parving, and R.H. Henning Microalbuminuria as an early marker for cardiovascular disease J Am Soc Nephrol 17 2006 2100 2105
44. M.R. Weir Microalbuminuria and cardiovascular disease Clin J Am Soc Nephrol 2 2007 581 590
45. R. Gnavi, R. Picariello, L.L. Karaghiosoff, G. Costa, and C. Giorda Determinants of quality in diabetes care process. The population-based Torino Study Diabetes Care 32 2009 1986 1992
46. H. Støvring, M. Andersen, H. Beck-Nielsen, A. Green, and W. Vach Counting drugs to understand the disease: the case of measuring the diabetes epidemic Popul Health Metrics 5 2007 2